PAG1 and breast carcinoma: Therefore, these results indicate that the PAG1/Cbp pathway is involved in breast cancer tumour progression and acquired chemoresistance and that the PAG1/Cbp pathway modulates MSC-promoted tumourigenesis via the Src and AKT/mTOR pathways [134].